Logo image of LFWD

LIFEWARD LTD (LFWD) Stock Fundamental Analysis

USA - NASDAQ:LFWD - IL0011331076 - Common Stock

0.75 USD
+0.01 (+1.42%)
Last: 10/13/2025, 6:33:32 PM
0.75 USD
0 (0%)
After Hours: 10/13/2025, 6:33:32 PM
Fundamental Rating

3

LFWD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. While LFWD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, LFWD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LFWD has reported negative net income.
In the past year LFWD has reported a negative cash flow from operations.
LFWD had negative earnings in each of the past 5 years.
LFWD had a negative operating cash flow in each of the past 5 years.
LFWD Yearly Net Income VS EBIT VS OCF VS FCFLFWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -111.13%, LFWD is not doing good in the industry: 79.06% of the companies in the same industry are doing better.
The Return On Equity of LFWD (-196.94%) is worse than 71.73% of its industry peers.
Industry RankSector Rank
ROA -111.13%
ROE -196.94%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
LFWD Yearly ROA, ROE, ROICLFWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

LFWD's Gross Margin of 35.60% is on the low side compared to the rest of the industry. LFWD is outperformed by 71.73% of its industry peers.
LFWD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LFWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
LFWD Yearly Profit, Operating, Gross MarginsLFWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFWD has more shares outstanding than it did 1 year ago.
LFWD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for LFWD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFWD Yearly Shares OutstandingLFWD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
LFWD Yearly Total Debt VS Total AssetsLFWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

LFWD has an Altman-Z score of -14.59. This is a bad value and indicates that LFWD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -14.59, LFWD is doing worse than 84.82% of the companies in the same industry.
There is no outstanding debt for LFWD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.59
ROIC/WACCN/A
WACC8.81%
LFWD Yearly LT Debt VS Equity VS FCFLFWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.00 indicates that LFWD should not have too much problems paying its short term obligations.
LFWD's Current ratio of 2.00 is on the low side compared to the rest of the industry. LFWD is outperformed by 64.92% of its industry peers.
LFWD has a Quick Ratio of 1.26. This is a normal value and indicates that LFWD is financially healthy and should not expect problems in meeting its short term obligations.
LFWD has a Quick ratio of 1.26. This is in the lower half of the industry: LFWD underperforms 67.02% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.26
LFWD Yearly Current Assets VS Current LiabilitesLFWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

LFWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.10%, which is quite impressive.
Looking at the last year, LFWD shows a small growth in Revenue. The Revenue has grown by 4.96% in the last year.
Measured over the past years, LFWD shows a very strong growth in Revenue. The Revenue has been growing by 39.41% on average per year.
EPS 1Y (TTM)34.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%-14.66%

3.2 Future

LFWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.23% yearly.
Based on estimates for the next years, LFWD will show a very strong growth in Revenue. The Revenue will grow by 42.62% on average per year.
EPS Next Y43.2%
EPS Next 2Y35.73%
EPS Next 3Y26.38%
EPS Next 5Y23.23%
Revenue Next Year-1.98%
Revenue Next 2Y21.38%
Revenue Next 3Y33.2%
Revenue Next 5Y42.62%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LFWD Yearly Revenue VS EstimatesLFWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
LFWD Yearly EPS VS EstimatesLFWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -200 -400 -600

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LFWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LFWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFWD Price Earnings VS Forward Price EarningsLFWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LFWD Per share dataLFWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

LFWD's earnings are expected to grow with 26.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.73%
EPS Next 3Y26.38%

More info and screens

0

5. Dividend

5.1 Amount

LFWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFEWARD LTD

NASDAQ:LFWD (10/13/2025, 6:33:32 PM)

After market: 0.75 0 (0%)

0.75

+0.01 (+1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners2.9%
Inst Owner ChangeN/A
Ins Owners2.07%
Ins Owner Change0%
Market Cap11.78M
Analysts82.5
Price Target5.61 (648%)
Short Float %7.83%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-52.56%
Min EPS beat(2)-86.44%
Max EPS beat(2)-18.68%
EPS beat(4)0
Avg EPS beat(4)-33.11%
Min EPS beat(4)-86.44%
Max EPS beat(4)-8.93%
EPS beat(8)1
Avg EPS beat(8)-20.89%
EPS beat(12)2
Avg EPS beat(12)-19.84%
EPS beat(16)3
Avg EPS beat(16)-24.5%
Revenue beat(2)0
Avg Revenue beat(2)-15.2%
Min Revenue beat(2)-16.17%
Max Revenue beat(2)-14.23%
Revenue beat(4)0
Avg Revenue beat(4)-16.23%
Min Revenue beat(4)-28.9%
Max Revenue beat(4)-5.62%
Revenue beat(8)1
Avg Revenue beat(8)-9.87%
Revenue beat(12)2
Avg Revenue beat(12)-13.99%
Revenue beat(16)3
Avg Revenue beat(16)-17.06%
PT rev (1m)0%
PT rev (3m)-15.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.44%
EPS NY rev (1m)3.16%
EPS NY rev (3m)-11.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-2.01
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS1.56
BVpS0.96
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -111.13%
ROE -196.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.6%
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.26
Altman-Z -14.59
F-Score4
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)5.59%
Cap/Depr(5y)12.01%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16%
EPS Next Y43.2%
EPS Next 2Y35.73%
EPS Next 3Y26.38%
EPS Next 5Y23.23%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%-14.66%
Revenue Next Year-1.98%
Revenue Next 2Y21.38%
Revenue Next 3Y33.2%
Revenue Next 5Y42.62%
EBIT growth 1Y31.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.5%
OCF growth 3YN/A
OCF growth 5YN/A